Tue, Oct 06, 2015 08:38 CET SenzaGen has just completed a share issue to accelerate the company’s rapidly growing revenues, scale up the sales organization, complete ongoing validation processes and develop new tests in the GARD portfolio. The interest has been overwhelming which is why the Company, at an Extraordinary General Meeting on Monday, October […]
About Malin Bergholm
This author has yet to write their bio.Meanwhile lets just say that we are proud Malin Bergholm contributed a whooping 64 entries.
Entries by Malin Bergholm
Tue, Aug 18, 2015 08:43 CET – We want a logo and a graphic profile that shows our identity, strengthens the brand and matches the quality of our products. We have been working together with a design and communications agency ID Communication in Malmö to find our tone and graphical language and we see this […]
Wed, Jun 17, 2015 06:50 CET Andy Forreryd of the Dept. of Immunotechnology won a “Best Abstract Presentation Price” at the Oral Abstract session entitled Risk factors and biomarkers in occupational allergy held at EAACI 2015 in Barcelona. Andy’s contribution was entitled Prediction of chemical respiratory sensitizers using GARD, a novel in vitro assay based […]
Wed, Jun 10, 2015 14:47 CET In June, SenzaGen moves into its new lab facilities at Medicon Village in Lund. As SenzaGen is expanding, establishing new partnerships and customers and is hiring more staff, the company has a demand to set up in new premises and gather the business. The lab is completely new and […]